StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
12
Publishing Date
2024 - 03 - 04
14
2023 - 12 - 21
13
2023 - 12 - 12
13
2023 - 12 - 06
14
2023 - 11 - 27
13
2023 - 10 - 23
12
2023 - 10 - 18
13
2023 - 10 - 16
16
2023 - 10 - 04
14
2023 - 09 - 26
18
2023 - 09 - 20
12
2023 - 09 - 07
15
2023 - 08 - 23
12
2023 - 06 - 26
13
2023 - 06 - 15
12
2023 - 04 - 27
12
2023 - 04 - 25
15
2023 - 04 - 17
15
2023 - 03 - 27
12
2023 - 02 - 23
13
2023 - 01 - 30
16
2023 - 01 - 26
12
2023 - 01 - 25
15
2023 - 01 - 04
12
2022 - 11 - 17
13
2022 - 10 - 12
14
2022 - 10 - 06
14
2022 - 09 - 14
14
2022 - 09 - 13
12
2022 - 08 - 22
13
2022 - 05 - 24
12
2022 - 05 - 17
13
2022 - 05 - 03
14
2022 - 03 - 28
14
2022 - 01 - 24
18
2021 - 12 - 22
12
2021 - 12 - 13
15
2021 - 12 - 09
12
2021 - 12 - 06
13
2021 - 11 - 01
12
2021 - 10 - 18
15
2021 - 10 - 14
12
2021 - 10 - 12
12
2021 - 10 - 07
12
2021 - 10 - 04
12
2021 - 09 - 07
12
2021 - 06 - 29
12
2021 - 06 - 25
13
2021 - 06 - 23
14
2021 - 06 - 21
13
2021 - 06 - 11
11
2021 - 06 - 04
13
2021 - 06 - 03
12
2021 - 06 - 01
14
2021 - 05 - 21
15
2021 - 05 - 03
14
2021 - 04 - 14
11
2021 - 03 - 22
13
2021 - 01 - 04
11
2020 - 12 - 21
12
Sector
Finance
1
Health technology
9
Manufacturing
4
Tags
Alzheimer
1
Alzheimer's
1
Alzheimer's disease
1
Alzheimer’s
1
Antibody
1
Approval
2
Atopic dermatitis
1
Bioforest
1
Bladder
1
Cancer
3
Cardio
2
Cardiologists
2
Clearance
1
Clinical-trials-phase-ii
1
Dermatitis
1
Disease
2
Drug
5
Enroll
2
Eye
2
Fda
1
Fda clearance
1
Fda-approvals
1
Gastrointestinal
1
Genetown
2
Hereditary angioedema
1
Mergers-and-acquisitions
1
N/a
5
New drug
2
Pdufa
1
Rare
1
Research
3
Results
2
Switzerland
1
Test
1
Therapy
1
Transdermal system
1
Treatment
12
Trial
3
Xin
1
Entities
Achilles therapeutics plc - adr
1
Astellas pharma inc
2
Astria therapeutics, inc.
1
Deciphera pharmaceuticals, inc.
1
Hercules capital, inc.
1
Hoth therapeutics, inc.
1
Johnson & johnson
1
Nanostring technologies, inc.
1
Protara therapeutics, inc.
1
Seagen inc.
2
Windtree therapeutics, inc.
2
Symbols
ACHL
1
ALPMF
2
ALPMY
2
ATXS
1
DCPH
1
HOTH
1
HTGC
1
JNJ
1
NSTG
1
SGEN
2
TARA
1
WINT
2
Exchanges
Nasdaq
10
Nyse
2
Crawled Date
2021 - 10 - 12
12
Crawled Time
11:00
1
12:00
5
12:15
1
13:00
1
13:15
1
14:00
2
14:15
1
Source
ir.hoththerapeutics.com
1
www.biospace.com
7
www.globenewswire.com
3
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
treatment
publishing date :
2021 - 10 - 12
save search
Corium Receives March 11, 2022 PDUFA Date for New Drug Application for ADLARITY® Patch (donepezil transdermal system) for Treatment of Patients with Alzheimer's Disease
Published:
2021-10-12
(Crawled : 14:15)
- biospace.com/
HTGC
F
|
$18.16
0.95%
-0.22%
730K
|
Finance
|
4.65%
|
O:
-0.06%
H:
0.64%
C:
-0.29%
new drug
disease
alzheimer
treatment
pdufa
drug
alzheimer’s
transdermal system
alzheimer's disease
alzheimer's
Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis Patients
Published:
2021-10-12
(Crawled : 14:00)
- ir.hoththerapeutics.com
HOTH
|
$1.19
-0.83%
-0.84%
24K
|
Health Technology
|
4.35%
|
O:
0.0%
H:
12.17%
C:
0.87%
treatment
dermatitis
trial
approval
atopic dermatitis
xin
Rejuveron leads EUR 15.7 million Series B investment in Rejuvenate Biomed to accelerate clinical development of its sarcopenia treatment for healthy aging
Published:
2021-10-12
(Crawled : 14:00)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.86%
|
O:
-0.16%
H:
0.11%
C:
-1.44%
treatment
Astria Therapeutics to Present Findings on Burdens of Disease and Treatment in Hereditary Angioedema at the 2021 NORD Rare Diseases and Orphan Products Breakthrough Summit
Published:
2021-10-12
(Crawled : 13:15)
- biospace.com/
ATXS
|
$10.53
-5.14%
-5.41%
550K
|
Manufacturing
|
50.2%
|
O:
0.0%
H:
5.68%
C:
4.47%
disease
treatment
rare
hereditary angioedema
Seagen and Astellas Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV® (enfortumab vedotin-ejfv) With Pembrolizumab as First-Line Treatment for Advanced Urothelial Cancer
Published:
2021-10-12
(Crawled : 13:00)
- biospace.com/
ALPMY
|
News
|
$9.34
-1.11%
690K
|
Manufacturing
|
-45.96%
|
O:
2.57%
H:
0.0%
C:
-2.82%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
41.07%
|
O:
0.22%
H:
2.27%
C:
1.35%
treatment
cancer
trial
enroll
Astellas and Seagen Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV® (enfortumab vedotin-ejfv) with Pembrolizumab as First-Line Treatment for Advanced Urothelial Cancer
Published:
2021-10-12
(Crawled : 12:00)
- prnewswire.com
ALPMY
|
News
|
$9.34
-1.11%
690K
|
Manufacturing
|
-45.96%
|
O:
2.57%
H:
0.0%
C:
-2.82%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
41.07%
|
O:
0.22%
H:
2.27%
C:
1.35%
treatment
cancer
trial
enroll
Market Research Finds 99% Of US Clinical Cardiologists Surveyed Report a High Unmet Need for New Innovative Drug Treatments for Early Cardiogenic Shock Patients (ECS) as Windtree Therapeutics Prepares for Clinical Results
Published:
2021-10-12
(Crawled : 12:15)
- biospace.com/
WINT
|
News
|
$0.3903
-7.4%
-7.99%
110K
|
Health Technology
|
-81.75%
|
O:
1.3%
H:
1.28%
C:
-2.56%
treatment
eye
cardiologists
results
drug
research
cardio
Protara Therapeutics Announces FDA Clearance of Investigational New Drug Application for TARA-002 for the Treatment of Non-Muscle Invasive Bladder Cancer
Published:
2021-10-12
(Crawled : 12:00)
- globenewswire.com
TARA
|
$2.75
-3.51%
-3.64%
170K
|
Health Technology
|
-57.78%
|
O:
15.1%
H:
2.33%
C:
-2.82%
new drug
fda clearance
treatment
fda
cancer
drug
clearance
bladder
Achilles Therapeutics to join the Northern Alliance Advanced Therapy Treatment Centre consortium
Published:
2021-10-12
(Crawled : 12:00)
- globenewswire.com
ACHL
|
$0.8
-0.27%
-0.28%
180K
|
Manufacturing
|
Email alert
Add to watchlist
treatment
therapy
Deciphera Announces Approval of QINLOCK® in Switzerland for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Published:
2021-10-12
(Crawled : 12:00)
- biospace.com/
DCPH
|
$14.72
-0.81%
-0.82%
300K
|
Health Technology
|
-54.06%
|
O:
0.19%
H:
7.51%
C:
6.61%
treatment
test
gastrointestinal
switzerland
approval
Market Research Finds 99% Of US Clinical Cardiologists Surveyed Report a High Unmet Need for New Innovative Drug Treatments for Early Cardiogenic Shock Patients (ECS) as Windtree Therapeutics Prepares for Clinical Results from its Istaroxime ECS Study
Published:
2021-10-12
(Crawled : 12:00)
- globenewswire.com
WINT
|
News
|
$0.3903
-7.4%
-7.99%
110K
|
Health Technology
|
-81.75%
|
O:
1.3%
H:
1.28%
C:
-2.56%
treatment
eye
cardiologists
results
drug
research
cardio
NanoString Launches nCounter Antibody Drug Conjugate Panel to Accelerate the Development of Oncology Treatments
Published:
2021-10-12
(Crawled : 11:00)
- biospace.com/
NSTG
|
News
|
$0.1053
-37.43%
-0.19%
0
|
Health Technology
|
-99.75%
|
O:
1.41%
H:
3.59%
C:
1.5%
treatment
antibody
drug
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.